LOUISVILLE, Ky. : The calls and emails started coming into NYU Langone Health and Massachusetts General Hospital soon after doctors began experimenting with pig organs in humans. “I think it’s worth the shot.” Now two U.S. companies aim to begin the world’s first clinical trials of xenotransplantation in 2025 – using pig kidneys or hearts to try to save human …
LOUISVILLE, Ky. — The calls and emails started coming into NYU Langone Health and Massachusetts General Hospital soon after doctors began experimenting with pig organs in humans. Pig kidney recipient Towana Looney sits with transplant surgeon Dr. Jayme Locke on Dec. 10, 2024, at NYU Langone Health, in New York City. Share Share Copy Link copied Email Facebook X Reddit …
Natco Pharma Ltd isn’t your run-of-the-mill pharmaceutical company. View Full Image Source: Investor Presentation Revlimid: A double-edged sword Revlimid, the blockbuster cancer drug, is the primary driver behind Natco’s financial performance in recent years. View Full Image Rajeev Nannapaneni is Vice Chairman/CEO at Natco Pharma Ltd. Risk of history repeating itself Natco’s journey is dotted with instances where its blockbuster …
Surgeons externally attached a pig liver to a brain-dead human body and watched it successfully filter blood, a step toward eventually trying the technique in patients with liver failure. In this case, the pig liver was used outside the donated body, not inside — a way to create a “bridge” to support failing livers by doing the organ’s blood-cleansing work …
